In cultured HBMEC, we further revealed that HDAC3 inhibition repressed Keap1 through miR-200a upregulation, thereby reducing Keap1-Nrf2 interaction and promoting Nrf2 activation, leading to the protective effects against T2DM-induced BBB permeability. Here, KEAP1 is linked to type 2 diabetes mellitus.